A Sept. 30 letter obtained from the office of Sen. Josh Hawley, R-Missouri, said the FDA approved the abbreviated new drug application for “mifepristone tablets” from Evita Solutions, a Virginia-based pharmaceutical company.

The FDA said in the letter that it had “concluded that adequate information has been presented to demonstrate that the drug meets the requirements for approval” under the Federal Food, Drug, and Cosmetic Act.

On its website as of Oct. 2, Evita Solutions was advertising a “new generic mifepristone product” coming to the U.S. Mifepristone constitutes one of the major components of abortion pill prescriptions. …

Continue reading >>>>>>>>>